Rebiotix, Inc.

Where therapeutic innovations have historically lagged, Freya Biosciences is developing novel microbiome-based treatments that could transform women’s reproductive health. Founded by a team of eight c

Clostridioides difficile infection (CDI) is a billion-dollar problem that microbiome-targeted companies are keen to solve. CDI is arguably the lowest-hanging fruit for microbiome-focused companies as

Just shy of three years after Ferring Pharmaceuticals and Blackstone formed FerGene to advance the late-stage bladder cancer gene therapy nadofaragene firadenovec, the pharma company and the priva

The waning of the COVID-19 pandemic was reflected in three FDA decisions issued last week for applications that had been under review long past their user fee goal dates because manufacturing inspecti